Marshall Wace
ASBPW

Marshall Wace’s Aspire Biopharma Warrant ASBPW Stock Holding History

Marshall Wace’s Portfolio ASBPW Stock Details ASBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-62,081
Closed -$770K – 3096
2024
Q3 		$770K Hold
62,081
– – ﹤0.01% 1758
2024
Q2 		$699K Hold
62,081
– – ﹤0.01% 1826
2024
Q1 		$697K Sell
62,081
-137,917
-69% -$5.39K ﹤0.01% 1797
2023
Q4 		$2.18M Hold
199,998
– – ﹤0.01% 1184
2023
Q3 		$2.33M Hold
199,998
– – ﹤0.01% 1158
2023
Q2 		$2.1M Hold
199,998
– – ﹤0.01% 1386
2023
Q1 		$2.1M Hold
199,998
– – ﹤0.01% 1431
2022
Q4 		$2.06M Hold
199,998
– – ﹤0.01% 1714
2022
Q3 		$2.03M Hold
199,998
– – ﹤0.01% 1998
2022
Q2 		$2M Buy
+199,998
New +$43.5K ﹤0.01% 1993

Other funds holding ASBPW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return